Zocto News
Category

News

4317 posts · page 16 of 180

Waystar Considers Sale Amid Software Sector Challenges
News

Waystar Considers Sale Amid Software Sector Challenges

Waystar is exploring a potential sale, two years after its public listing, amid a downturn in software valuations.

Trump Administration's A.I. Health Push Raises Safety Concerns
News

Trump Administration's A.I. Health Push Raises Safety Concerns

Federal A.I. health initiatives face scrutiny over safety and investor influence.

GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
News

GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences

GE HealthCare is negotiating a $1 billion acquisition of Sofie Biosciences, aiming to enhance its diagnostic capabilities.

MedTech Industry Supports Maharashtra FDA's Call for Fairer Pricing
News

MedTech Industry Supports Maharashtra FDA's Call for Fairer Pricing

Maharashtra FDA's push for transparent pricing gains support from MedTech sector amid massive price disparities in hospital consumables.

Manipal Hospitals Clears Rs 5,310 Crore Debt Using IPO Funds
News

Manipal Hospitals Clears Rs 5,310 Crore Debt Using IPO Funds

Manipal Hospitals has fully repaid Rs 5,310 crore in debt using funds raised from its IPO, bolstering its financial position.

Fortis to Manage 400-Bed Hospital in Delhi's Ashok Vihar
News

Fortis to Manage 400-Bed Hospital in Delhi's Ashok Vihar

Fortis signs a 29-year agreement with SLJ Society to manage a 400-bed hospital in Ashok Vihar, Delhi, focusing on advanced healthcare services.

Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Post-IPO
News

Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Post-IPO

Molbio Diagnostics sees a strong Q1 with Rs 52.7 crore profit, reversing last year's loss.

Indian AI Platform iOncology.ai Showcased in BRICS Health Journal
News

Indian AI Platform iOncology.ai Showcased in BRICS Health Journal

iOncology.ai, an AI-driven cancer care platform from India, gains attention at the BRICS Summit, highlighting its potential in transforming cancer treatment in emerging economies.

Waystar Considers Sale Amid Software Sector Turbulence
News

Waystar Considers Sale Amid Software Sector Turbulence

Healthcare software firm Waystar explores strategic options, including a potential sale, as its market value declines.

Trump Administration Pushes A.I. in Healthcare Amid Safety Concerns
News

Trump Administration Pushes A.I. in Healthcare Amid Safety Concerns

The Trump administration is advancing A.I. in healthcare, sparking debate over safety and investor influence.

GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
News

GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences

GE HealthCare is reportedly negotiating a $1 billion acquisition of Sofie Biosciences, a company known for its cancer diagnostic chemicals.

Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Post-IPO
News

Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Post-IPO

Molbio Diagnostics posts Rs 52.7 crore profit in Q1, reversing last year's loss, driven by Truenat test-kit demand.

Indian AI Platform iOncology.ai Featured in BRICS Health Journal
News

Indian AI Platform iOncology.ai Featured in BRICS Health Journal

iOncology.ai, an AI-driven cancer care platform by AIIMS and C-DAC, gains global recognition at the BRICS Summit.

Waystar Weighs Sale as Software Sector Faces Market Challenges
News

Waystar Weighs Sale as Software Sector Faces Market Challenges

Waystar explores strategic options, including a sale, amid declining market value.

AI Integration in Healthcare: Trump Administration's Controversial Move
News

AI Integration in Healthcare: Trump Administration's Controversial Move

The Trump administration is advancing AI in healthcare, sparking safety and investor influence concerns.

GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
News

GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences

GE HealthCare is negotiating a $1 billion acquisition of Sofie Biosciences, known for cancer scan chemicals, potentially finalizing next week.

Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO Success
News

Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO Success

Molbio Diagnostics announced a Rs 52.7 crore profit for Q1, a significant turnaround from last year's loss, boosted by strong Truenat kit sales.

Indian AI Cancer Platform iOncology.ai Gains Spotlight in BRICS Health Journal
News

Indian AI Cancer Platform iOncology.ai Gains Spotlight in BRICS Health Journal

iOncology.ai, a cancer care AI platform from India, features in BRICS Health Journal, highlighting its role in early detection and treatment planning.

Waystar Mulls Strategic Options, Including Possible Sale
News

Waystar Mulls Strategic Options, Including Possible Sale

Waystar, a healthcare software firm, is exploring potential sale options amid declining stock values, sources reveal.

AI in Healthcare: Trump Admin Pushes Forward Amid Safety Concerns
News

AI in Healthcare: Trump Admin Pushes Forward Amid Safety Concerns

The Trump administration's AI healthcare initiatives face scrutiny over safety and investor influence.

GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
News

GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences

GE HealthCare is negotiating a $1 billion acquisition of Sofie Biosciences, a leader in cancer imaging chemicals.

Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO
News

Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO

Molbio Diagnostics, newly listed on the stock market, reports a Rs 52.7 crore profit for Q1, reversing last year's loss.

Indian AI Cancer Care Platform Showcased at BRICS Health Summit
News

Indian AI Cancer Care Platform Showcased at BRICS Health Summit

iOncology.ai, developed by AIIMS and C-DAC, gains recognition at BRICS for its potential to revolutionize cancer care.

Waystar Considers Sale Amid Software Sector Challenges
News

Waystar Considers Sale Amid Software Sector Challenges

Healthcare software firm Waystar is exploring a potential sale, following a significant decline in its market value.